Great progress has been made in many countries to tackle the HIV epidemic. A newly diagnosed patient with access to the latest antiretroviral therapy (ART) can hope to have a normal life expectancy. Yet, over 30 years since the emergence of the virus, and 30 years since the first World’s AIDS Day, much more needs to done to bring these advances to developing countries and to reach groups at high risk of HIV transmission. One of the biggest barriers to achieving this aim is the stigma that is still rife in many countries.
One-stop resource for pharmacists in HIV careSubscription
HIV pharmacotherapy: the pharmacist’s role in care and treatment, edited by Jason J Schafer, Jennifer M Cocohoba, Elizabeth M Sherman and Alice L Tseng.
Optimising the health and wellbeing of older people living with HIV in the United Kingdom Subscription
Care for people with HIV has improved, meaning that more people are living with HIV into older age with normal life expectancy. Therefore, there are various challenges and opportunities facing healthcare professionals when providing care to this changing demographic.
The World Health Organization warns of increasing HIV drug resistance and issues new guidelines to address threatSubscription
Meg Caroline Doherty from the World Health Organization discusses the increasing number of cases HIV drug resistance, and the new guidelines and global action plan developed by the WHO to help countries address the threat.
HIV services need to evolve to meet new needsSubscription
A stronger, less fragmented system of HIV services is needed in order to keep pace with the changing needs of patients.
None of the more than 1,000 people in Wales who have received pre-exposure prophylaxis since it became routinely available have developed HIV while receiving the drugs.
More than a quarter of the sexual health clinics involved in NHS England’s PrEP Impact Trial are currently closed to new recruits, despite a promised expansion, a health minister has revealed.
Incidence of hepatitis C has fallen by almost 70% in HIV positive men who have sex with men living in London since 2015, according to research presented at a major HIV conference.
NHS England has announced that it will now start to release additional spaces on its PrEP Impact Trial.
Rollout of pre-exposure prophylaxis for HIV has resulted in a rapid decrease of new infections among men who have sex with men, according to data collected in New South Wales, Australia.
Study highlights a need for adolescent men who have sex with men to be given pre-exposure prophylaxis and for adherence to be promoted in this group.
A vaginal ring containing the antiretroviral drug dapivirine had high adherence among young women, study finds